Preoperative Administration of Olaparib With Cisplatin or With Durvalumab or Alone or no Tratment in Patients Who Are Candidates for Surgery of Carcinoma of the Head and Neck.

NCT02882308 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

41

Enrollment

OTHER

Sponsor class

Conditions

Squamous Cell Carcinoma of the Head and Neck

Interventions

DRUG: Olaparib
DRUG: Cisplatin
DRUG: Olaparib
DRUG: Durvalumab

Sponsor

Hellenic Cooperative Oncology Group

Collaborators

[object Object]